Colossal Biosciences, the world’s first de-extinction company, has today announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (“USIT”). Colossal will leverage this latest infusion of capital to continue to advance genetic engineering and pioneer new revolutionary software, wetware and hardware solutions. As part of its Series B, Colossal has also announced the launch of its Avian Genomics Group, which will pursue the de-extinction of the Dodo. Source: Business Wire 31/1/2023